DT
CHRS icon

Diversified Trust’s Coherus Oncology CHRS Stock Holding History

Diversified Trust’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,471
Closed -$65K – 1136
2026
Q1 		$65K Buy
38,471
+10,312
+37% +$18.3K ﹤0.01% 1022
2025
Q4 		$40K Hold
28,159
– – ﹤0.01% 1021
2025
Q3 		$46.2K Hold
28,159
– – ﹤0.01% 980
2025
Q2 		$20.6K Buy
+28,159
New +$24.3K ﹤0.01% 925

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Diversified Trust's CHRS Position: Q2 2026 in Review

Diversified Trust sold out of Coherus Oncology (CHRS) in Q2 2026, closing a stake of 38,471 shares — an estimated $65K sold.

Diversified Trust first reported a position in CHRS in Q2 2025 and held it in 4 quarters. The position peaked at $65K in Q1 2026. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Diversified Trust reported no remaining Coherus Oncology position as of Q2 2026 after selling out during the quarter.
  • Diversified Trust sold 38,471 Coherus Oncology shares in Q2 2026, an estimated $65K.
  • Diversified Trust first reported a position in Coherus Oncology in Q2 2025 and held it in 4 quarters.
  • Diversified Trust's Coherus Oncology position peaked at $65K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.